vs
CVRx, Inc.（CVRX）与Dominari Holdings Inc.（DOMH）财务数据对比。点击上方公司名可切换其他公司
Dominari Holdings Inc.的季度营收约是CVRx, Inc.的1.9倍（$30.1M vs $16.0M），CVRx, Inc.净利率更高（-74.5% vs -438.1%，领先363.6%），Dominari Holdings Inc.同比增速更快（220.4% vs 4.4%），过去两年Dominari Holdings Inc.的营收复合增速更高（369.1% vs 22.0%）
CVRx, Inc.是一家处于商业化阶段的医疗科技企业，专注于慢性心血管疾病神经调节疗法的研发与商业化，旗舰产品Barostim系统用于治疗心力衰竭和难治性高血压，核心市场覆盖北美、欧洲，服务对常规药物治疗应答不佳的患者。
CVRX vs DOMH — 直观对比
营收规模更大
DOMH
是对方的1.9倍
$16.0M
营收增速更快
DOMH
高出216.0%
4.4%
净利率更高
CVRX
高出363.6%
-438.1%
两年增速更快
DOMH
近两年复合增速
22.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.0M | $30.1M |
| 净利润 | $-11.9M | $-131.8M |
| 毛利率 | 86.3% | — |
| 营业利润率 | -69.8% | -8.9% |
| 净利率 | -74.5% | -438.1% |
| 营收同比 | 4.4% | 220.4% |
| 净利润同比 | -12.0% | -12426.2% |
| 每股收益（稀释后） | $-0.45 | $-6.94 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVRXDOMH
| Q4 25 | $16.0M | $30.1M | ||
| Q3 25 | $14.7M | $50.8M | ||
| Q2 25 | $13.6M | $34.1M | ||
| Q1 25 | $12.3M | $8.1M | ||
| Q4 24 | $15.3M | $9.4M | ||
| Q3 24 | $13.4M | $4.0M | ||
| Q2 24 | $11.8M | $6.2M | ||
| Q1 24 | $10.8M | $1.4M |
净利润CVRXDOMH
| Q4 25 | $-11.9M | $-131.8M | ||
| Q3 25 | $-12.9M | $125.2M | ||
| Q2 25 | $-14.7M | $16.6M | ||
| Q1 25 | $-13.8M | $-32.5M | ||
| Q4 24 | $-10.7M | $1.1M | ||
| Q3 24 | $-13.1M | $-4.2M | ||
| Q2 24 | $-14.0M | $-6.1M | ||
| Q1 24 | $-22.2M | $-5.4M |
毛利率CVRXDOMH
| Q4 25 | 86.3% | — | ||
| Q3 25 | 86.8% | — | ||
| Q2 25 | 84.3% | — | ||
| Q1 25 | 83.5% | — | ||
| Q4 24 | 83.2% | — | ||
| Q3 24 | 83.2% | — | ||
| Q2 24 | 83.9% | — | ||
| Q1 24 | 85.0% | — |
营业利润率CVRXDOMH
| Q4 25 | -69.8% | -8.9% | ||
| Q3 25 | -83.5% | -3.1% | ||
| Q2 25 | -105.8% | -57.0% | ||
| Q1 25 | -108.8% | -394.6% | ||
| Q4 24 | -67.0% | 0.4% | ||
| Q3 24 | -97.3% | -79.1% | ||
| Q2 24 | -118.3% | -44.3% | ||
| Q1 24 | -206.4% | -205.2% |
净利率CVRXDOMH
| Q4 25 | -74.5% | -438.1% | ||
| Q3 25 | -87.6% | 246.4% | ||
| Q2 25 | -108.4% | 48.7% | ||
| Q1 25 | -111.5% | -400.5% | ||
| Q4 24 | -69.4% | 11.4% | ||
| Q3 24 | -98.0% | -104.2% | ||
| Q2 24 | -118.8% | -99.1% | ||
| Q1 24 | -206.0% | -398.0% |
每股收益（稀释后）CVRXDOMH
| Q4 25 | $-0.45 | $-6.94 | ||
| Q3 25 | $-0.49 | $7.27 | ||
| Q2 25 | $-0.57 | $1.12 | ||
| Q1 25 | $-0.53 | $-3.02 | ||
| Q4 24 | $-0.39 | $0.21 | ||
| Q3 24 | $-0.57 | $-0.67 | ||
| Q2 24 | $-0.65 | $-1.01 | ||
| Q1 24 | $-1.04 | $-0.91 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $75.7M | $80.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $39.3M | $69.4M |
| 总资产 | $104.8M | $112.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CVRXDOMH
| Q4 25 | $75.7M | $80.5M | ||
| Q3 25 | $85.1M | $176.2M | ||
| Q2 25 | $95.0M | $28.2M | ||
| Q1 25 | $102.7M | $18.9M | ||
| Q4 24 | $105.9M | $8.2M | ||
| Q3 24 | $100.2M | $7.2M | ||
| Q2 24 | $70.4M | $12.1M | ||
| Q1 24 | $80.1M | $7.1M |
股东权益CVRXDOMH
| Q4 25 | $39.3M | $69.4M | ||
| Q3 25 | $48.1M | $210.2M | ||
| Q2 25 | $57.9M | $88.6M | ||
| Q1 25 | $71.1M | $42.4M | ||
| Q4 24 | $71.1M | $39.9M | ||
| Q3 24 | $65.2M | $38.3M | ||
| Q2 24 | $55.2M | $42.4M | ||
| Q1 24 | $66.3M | $47.7M |
总资产CVRXDOMH
| Q4 25 | $104.8M | $112.9M | ||
| Q3 25 | $111.3M | $223.4M | ||
| Q2 25 | $119.6M | $109.3M | ||
| Q1 25 | $129.6M | $52.3M | ||
| Q4 24 | $133.4M | $47.1M | ||
| Q3 24 | $127.7M | $43.4M | ||
| Q2 24 | $96.0M | $49.1M | ||
| Q1 24 | $106.2M | $52.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-9.8M | $22.7M |
| 自由现金流经营现金流 - 资本支出 | $-9.8M | — |
| 自由现金流率自由现金流/营收 | -61.3% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-40.8M | — |
8季度趋势，按日历期对齐
经营现金流CVRXDOMH
| Q4 25 | $-9.8M | $22.7M | ||
| Q3 25 | $-9.7M | $-4.9M | ||
| Q2 25 | $-7.9M | $-353.0K | ||
| Q1 25 | $-12.8M | $1.2M | ||
| Q4 24 | $-8.0M | $-16.7M | ||
| Q3 24 | $-10.4M | $-4.7M | ||
| Q2 24 | $-9.8M | $1.4M | ||
| Q1 24 | $-10.9M | $-8.6M |
自由现金流CVRXDOMH
| Q4 25 | $-9.8M | — | ||
| Q3 25 | $-10.0M | — | ||
| Q2 25 | $-8.0M | — | ||
| Q1 25 | $-12.9M | — | ||
| Q4 24 | $-8.1M | — | ||
| Q3 24 | $-10.4M | — | ||
| Q2 24 | $-10.2M | — | ||
| Q1 24 | $-11.8M | — |
自由现金流率CVRXDOMH
| Q4 25 | -61.3% | — | ||
| Q3 25 | -68.1% | — | ||
| Q2 25 | -59.2% | — | ||
| Q1 25 | -104.3% | — | ||
| Q4 24 | -52.5% | — | ||
| Q3 24 | -78.1% | — | ||
| Q2 24 | -86.3% | — | ||
| Q1 24 | -109.7% | — |
资本支出强度CVRXDOMH
| Q4 25 | 0.4% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 8.5% | — |
现金转化率CVRXDOMH
| Q4 25 | — | — | ||
| Q3 25 | — | -0.04× | ||
| Q2 25 | — | -0.02× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -15.65× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVRX
| US | $14.9M | 93% |
| Other | $1.1M | 7% |
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
